Press release
Early Cancer Detection Market is Projected to Grow at a CAGR of 13.8% from 2019-2028 | Grail (Illumina) LLC., Exact Sciences, Gaurdant Health, BGI Genomics, Epigenomics AG
Early Cancer Detection Market
How big is the Early Cancer Detection market?
The Global Early Cancer Detection Market is expected to grow at more than 13.8% CAGR from 2019 to 2028. It is expected to reach above USD 2,650 million by 2028 from a little above USD 909 million in 2019.
Request for a free sample copy of this report-> https://exactitudeconsultancy.com/reports/1092/early-cancer-detection-market/#request-a-sample
**Note - Updated Version 2023 is available
Why is early cancer diagnosis important?
Spotting cancer at an early stage saves lives.
Diagnosing cancer when it isn't too large and hasn't spread means that treatment is more likely to be successful.
You know your body best, so if something doesn't feel quite right talk to your doctor.
Market Overview
Wider skill sets outside cancer biology, such as those of engineers, chemists, physicists, technology developers, and behavioural and computer scientists, are necessary for early diagnosis to achieve dramatic progress in cancer survival. Innovative solutions to the problems of early cancer diagnosis must be developed through integrated, interdisciplinary collaboration. Given the unparalleled rate of biological understanding and technical advancement as well as the rising willingness of both public and private donors to spend in research, we feel that early diagnosis of cancer is on the verge of a tipping point. This Review analyses the current status of the field and makes helpful recommendations for the future that build on existing advancements to provide effective earlier cancer detection and suitable response.
Who are the major players in this industry?
Grail (Illumina) LLC., Exact Sciences, Gaurdant Health, BGI Genomics, Epigenomics AG, Genetron Health, Berry Genomics, New Horizon Health, and others.
Recent Developments
August 07, 2023 Exact Sciences Presents New Long-Term Patient Outcomes In Multi-Cancer Early Detection And Breast Cancer Recurrence Testing At Asco® 2023
Exact Sciences Corp. a leading provider of cancer screening and diagnostic tests, announced today that it will present 15 abstracts at the American Society of Clinical Oncology® (ASCO®) Annual Meeting 2023, June 2-6, in Chicago, Illinois. Presentations include new data confirming Exact Sciences' approach to multi-cancer early detection (MCED), real-world outcomes using the Oncotype DX Breast Recurrence Score®, and modeling comparisons between Cologuard® and potential blood-based screening tests for colorectal cancer.
Jun 05, 2023 Early Adopters Share Experiences With Grail Cancer Test as Firm Faces New Clinical Questions
What exactly does market segmentation cover?
Early Cancer Detection Market By Type, (IN USD Million)
CTC
CtDNA
Exosomes
Blood Proteomics
Others
Early Cancer Detection Market By Application, (IN USD Million)
Hospitals
Diagnostic Laboratories
Clinics
Others
Regional Growth Dynamics of the Early Cancer Detection Market
Asia Pacific region is witnessing the growth in market.
The market development, current market trends, and some research methodologies are all covered in the Early Cancer Detection Industry research report. It draws attention to crucial aspects like product portfolios, software architectures, and production strategies that have a direct impact on the market. Our research shows that even minor changes to a product's qualities can have a big impact on the previously mentioned criteria.
Europe (Germany, France, the United Kingdom, Russia, Italy)
Southeast Asia, China, Japan, South Korea, and Asia-Pacific
Brazil, Argentina, Colombia, etc. are all in South America.
Americas (US, Canada, and Mexico)
Middle East and Africa (Saudi Arabia, United Arab Emirates, Egypt, Nigeria, and South Africa)
Table of Content:
1 Study Reporting
1.1 Early Cancer Detection Product
1.2 Key Segments in This Study
1.3 Key Companies Covered
1.4 Market by Type
1.4.1 Global Early Cancer Detection Market Size Growth Rate by Type
1.5 Market by Application
2 Executive Instantaneous
2.1 Global Early Cancer Detection Market Size
2.1.1 Global Early Cancer Detection Revenue
2.1.2 Global Early Cancer Detection Production
2.2 Early Cancer Detection Growth Rate (CAGR)
2.3 Analysis of Competitive Landscape
2.3.1 Manufacturers Market Concentration Ratio
2.3.2 Key Early Cancer Detection Manufacturers
2.3.2.1 Early Cancer Detection Manufacturing Base Distribution, Headquarters
2.3.2.2 Manufacturers Early Cancer Detection Product Offered
2.3.2.3 Date of Manufacturers Enter into Early Cancer Detection Market
2.4 Key Trends for Early Cancer Detection Markets & Products
3 Market Size by Manufacturers
3.1 Early Cancer Detection Production by Manufacturers
3.2 Mergers & Acquisitions, Expansion Plans
4 Early Cancer Detection Production by Regions
4.1 Global Early Cancer Detection Production by Regions
4.1.1 Global Early Cancer Detection Production Market Share by Regions
4.1.2 Global Early Cancer Detection Revenue Market Share by Regions
4.2 United States
4.2.1 United States Early Cancer Detection Production
4.2.2 United States Early Cancer Detection Revenue
4.2.3 Key Players in United States
4.2.4 United States Early Cancer Detection Import & Export
4.3 Europe
4.3.1 Europe Early Cancer Detection Production
4.3.2 Europe Early Cancer Detection Revenue
5 Early Cancer Detection Consumption by Regions
5.1 Global Early Cancer Detection Consumption by Regions
5.1.1 Consumption by Regions
5.1.2 Consumption Market Share by Regions
5.2 North America
5.2.1 North America Consumption by Application
5.2.2 North America Consumption by Countries
5.2.3 United States
5.2.4 Canada
5.2.5 Mexico
5.3 Europe
5.3.1 Europe Consumption by Application
5.3.2 Europe Consumption by Countries
5.3.3 Germany
5.3.4 France
5.3.5 UK
5.3.6 Italy
5.3.7 Russia
5.4 Asia Pacific
5.4.1 Asia Pacific Consumption by Application
5.4.2 Asia Pacific Consumption by Countries
5.5.1 Central & South America) Consumption by Application
5.5.2 Central & South America Consumption by Country
6 Market Size by Type
6.1 Production by Type
6.2 Revenue by Type
6.3 Price by Type
7 Market Size by Application
7.1 Overview
7.2 Global Early Cancer Detection Breakdown Dada by Application
7.2.1 Global Early Cancer Detection Consumption by Application
7.2.2 Global Early Cancer Detection Consumption Market Share by Application
8 Manufacturers Profiles
9 Production Forecasts
9.1 Early Cancer Detection Production and Revenue Forecast
9.1.1 Global Early Cancer Detection Production Forecast
9.1.2 Global Early Cancer Detection Revenue Forecast
9.2 Early Cancer Detection Production and Revenue Forecast by Regions
9.2.1 Global Early Cancer Detection Revenue Forecast by Regions
9.2.2 Global Early Cancer Detection Production Forecast by Regions
9.3 Early Cancer Detection Key Producers Forecast
9.3.1 United States
9.3.2 Europe
9.3.3 China
9.3.4 Japan
9.4 Forecast by Type
9.4.1 Global Early Cancer Detection Production Forecast by Type
9.4.2 Global Early Cancer Detection Revenue Forecast by Type
10 Consumption Forecast
10.1 Early Cancer Detection Consumption Forecast by Application
10.2 Early Cancer Detection Consumption Forecast by Regions
10.3 North America Market Consumption Forecast
10.3.1 North America Early Cancer Detection Consumption Forecast by Regions
10.3.2 United States
10.3.3 Canada
10.3.4 Mexico
10.4 Europe Market Consumption Forecast
10.4.1 Europe Early Cancer Detection Consumption Forecast by Regions 2018-2025
10.4.2 Germany
10.4.3 France
10.4.4 UK
10.4.5 Italy
10.4.6 Russia
10.5 Asia Pacific Market Consumption Forecast
10.5.1 Asia Pacific Early Cancer Detection Consumption Forecast by Regions
10.5.2 China
10.5.3 Japan
10.5.4 South Korea
10.5.5 India
10.5.6 Australia
10.5.7 Indonesia
10.5.8 Thailand
10.5.9 Malaysia
10.5.10 Philippines
10.5.11 Vietnam
10.6 Central & South America Market Consumption Forecast
10.6.1 Central & South America Early Cancer Detection Consumption Forecast by Regions
10.6.2 Brazil
10.7 Middle East and Africa Market Consumption Forecast
10.7.1 Middle East and Africa Early Cancer Detection Consumption Forecast by Regions
10.7.2 GCC Countries
10.7.3 Egypt
10.7.4 South Africa
11 Value Chain and Sales Channels Analysis
11.1 Value Chain Analysis
11.2 Sales Channels Analysis
11.2.1 Early Cancer Detection Sales Channels
11.2.2 Early Cancer Detection Distributors
11.3 Early Cancer Detection Customers
12 Market Opportunities & Challenges, Risks and Influences Factors Analysis
12.1 Market Opportunities and Drivers
12.2 Market Challenges
12.3 Market Risks/Restraints
12.4 Key World Economic Indicators
13 Key Findings in the Global Early Cancer Detection Study
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.1.1 Research Programs/Design
14.1.1.2 Market Size Estimation
14.1.1.3 Market Breakdown and Data Triangulation
14.1.2 Data Source
14.1.2.1 Secondary Sources
14.1.2.2 Primary Sources
14.2 Author Details
14.3 Disclaimer
Continue….
Benefits of Early Cancer Detection Market Reports
✣ Customer Satisfaction Our team of professionals helps you with all of your research needs and optimises your reports.
✣ Analyst Support: Ask a seasoned analyst to respond to your inquiries before or after purchasing the report.
✣ Assured Quality: Emphasises the reliability and calibre of reports.
✣ Unmatched Skills: Analysts offer in-depth analyses of reports.
Detail Information@ https://exactitudeconsultancy.com/reports/1092/early-cancer-detection-market/#request-a-sample
Healthcare trending Reports
https://www.digitaljournal.com/pr/news/xherald/healthcare-education-market-size-usd-161-billion-by-2028-a-growing-industry-and-its-impact-on-healthcare-systems
https://www.digitaljournal.com/pr/news/xherald/digital-therapeutics-dtx-market-updates-2023-to-surpass-usd-26-84-billion-by-2029-report
https://www.digitaljournal.com/pr/news/xherald/early-cancer-detection-market-size-growing-at-13-8-cagr-set-to-reach-usd-2-650-million-by-2028-exclusive-report
https://www.digitaljournal.com/pr/news/xherald/microcatheters-market-research-is-predicted-to-witness-substantial-expansion-exhibit-cagr-of-5-5-by-2028-report
https://www.digitaljournal.com/pr/news/xherald/north-america-assays-market-will-grow-at-a-cagr-of-8-1-by-2029
About Us
Exactitude Consultancy is a Market research & consulting services firm which helps its client to address their most pressing strategic and business challenges. Our professional team works hard to fetch the most authentic research reports backed with impeccable data figures which guarantee outstanding results every time for you. So, whether it is the latest report from the researchers or a custom requirement, our team is here to help you in the best possible way.
Connect Us:
PHONE NUMBER +1 (704) 266-3234
EMAIL ADDRESS: sales@exactitudeconsultancy.com
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Early Cancer Detection Market is Projected to Grow at a CAGR of 13.8% from 2019-2028 | Grail (Illumina) LLC., Exact Sciences, Gaurdant Health, BGI Genomics, Epigenomics AG here
News-ID: 3189921 • Views: …
More Releases from Exactitude Consultancy
Huntington's Disease Market to Set Phenomenal Growth From 2025 to 2034
Introduction
Huntington's Disease (HD) is a devastating rare, inherited neurodegenerative disorder that progressively impairs movement, cognition, and behavior. Affecting approximately 3 to 7 individuals per 100,000 globally, it continues to challenge patients, caregivers, and healthcare systems. Despite being rare, the growing investment in research, clinical trials, and novel treatment approaches is transforming the Huntington's Disease market into a promising frontier for biopharmaceutical innovation.
The global Huntington's Disease market is poised for strong…
Hemophilia B Market Emerging Trends and Growth Prospects 2034
Introduction
Hemophilia B is a rare, inherited bleeding disorder caused by a deficiency or dysfunction of clotting factor IX (FIX). Patients with Hemophilia B experience prolonged bleeding episodes, spontaneous internal hemorrhages, and joint damage, which can significantly impair quality of life. The disease predominantly affects males, with an estimated 1 in 25,000 male births worldwide.
For decades, the mainstay of treatment has been factor IX replacement therapy, delivered intravenously. However, repeated infusions,…
Lupus Nephritis Patient Pool Analysis Market is expected to reach USD 15.2 billi …
Lupus nephritis (LN) is a severe manifestation of systemic lupus erythematosus (SLE), an autoimmune disease where the immune system attacks the body's own tissues. LN affects the kidneys, causing inflammation that can lead to organ damage and, if left untreated, kidney failure. With SLE most commonly affecting women of childbearing age, lupus nephritis represents a significant clinical and socioeconomic burden worldwide.
Download Full PDF Sample Copy of Market Report @ https://exactitudeconsultancy.com/request-sample/71619
The…
Facioscapulohumeral Muscular Dystrophy (FSHD) Market Massive Growth opportunity …
Introduction
Facioscapulohumeral muscular dystrophy (FSHD) is a rare genetic muscle disorder characterized by progressive weakness of facial, shoulder, and upper arm muscles, and eventually lower body muscles. It is the third most common type of muscular dystrophy, affecting approximately 1 in 8,000 to 1 in 20,000 individuals worldwide.
FSHD is typically caused by abnormal expression of the DUX4 gene due to genetic mutations on chromosome 4. While there is currently no approved…
More Releases for Cancer
Cancer Therapeutics Market New Business Opportunities to Hit $180.19 billion by …
Surge in geriatric population and rise in the number of collaborations & partnerships to facilitate drug development are the key drivers of the global cancer therapeutics market. In addition, heavy inflow of investment in R&D activities has enhanced the development of cancer therapeutics. Furthermore, favorable government regulations for cancer therapeutics and surge in cancer prevalence boost the market. The high demand for personalized medicine along with high potential of emerging…
Global Cancer Diagnostics Market Size, Trends & Growth Opportunity By Applicatio …
Cancer diagnostics is a process of detecting various proteins, biomarkers and certain symptoms that result in the detection of presence of cancerous tumour in patients. Detection of certain proteins and biomarkers which are prevalent in cancer disorder thereby results in diagnosis process. Cancer diagnostics includes usage of certain technology and devices for detection purpose.
Increase in incidence of target diseases like cancer is key driving factor which is expected to boost…
2019-2027 Oncology Nutrition Market is driven by Major Cancer Type - Head and Ne …
The "Global Oncology Nutrition Market Analysis to 2027" is a specialized and in-depth study with a special focus on the global market trend analysis. The report aims to provide an overview of oncology nutrition market with detailed market segmentation by cancer type and geography. The global oncology nutrition market is expected to witness high growth during the forecast period. The report provides key statistics on the market status of the…
Cancer Immunotherapy Market 2018 To 2025 - SWOT Analysis By Global Industry Reve …
The Cancer Immunotherapy Market research report provided by Crystal Market Research (CMR) is the most detailed study about Cancer Immunotherapy Market that is estimated to grow at a tremendous rate over the forecast period 2018-2025. This report contains precise and updated insights in respect with the leading market players and prevailing regions of the business.
Cancer Immunotherapy Market By Product and Cancer Type - Global Industry Analysis And Forecast To 2025:…
Oncology Nutrition Market by Cancer Type Breast Cancer, Liver Cancer, Lung Cance …
Lunch of new products for nutrition of oncology patients is expected to drive the oncology nutrition market growth. For instance, in 2016, Hormel Food Corporation, a U.S-based meat food products company, launched a line of packaged ready-to-eat meals for cancer patients, which are called as Hormel Vital Cuisine.
These meals consist of carbohydrates, proteins, and fats to help patients fight loss of muscle mass and energy during cancer treatment. Thus launch…
Tumor Ablation Global Market From 2014 - 2024: Segmented Into Liver Cancer, Lung …
Researchmoz added Most up-to-date research on "Tumor Ablation Global Market From 2014 - 2024: Segmented Into Liver Cancer, Lung Cancer, Kidney Cancer, Bone Cancer, Breast Cancer, Prostate Cancer, And Others" to its huge collection of research reports.
Tumor ablation is the removal of the tumor cells or tissue with minimally invasive procedure. Tumor ablation devices are consists of an applicator (catheter), which is introduced into the tumor under imaging guidance. For…
